Neuroscience Research Institute and Department of Neurobiology, Peking University, Beijing, People's Republic of China.
PLoS One. 2013;8(3):e58957. doi: 10.1371/journal.pone.0058957. Epub 2013 Mar 14.
Bone cancer pain seriously affects the quality of life of cancer patients. Our previous study found that endogenous formaldehyde was produced by cancer cells metastasized into bone marrows and played an important role in bone cancer pain. However, the mechanism of production of this endogenous formaldehyde by metastatic cancer cells was unknown in bone cancer pain rats. Lysine-specific demethylase 1 (LSD1) is one of the major enzymes catalyzing the production of formaldehyde. The expression of LSD1 and the concentration of formaldehyde were up-regulated in many high-risk tumors.
This study aimed to investigate whether LSD1 in metastasized MRMT-1 breast cancer cells in bone marrows participated in the production of endogenous formaldehyde in bone cancer pain rats.
METHODOLOGY/PRINCIPAL FINDINGS: Concentration of the endogenous formaldehyde was measured by high performance liquid chromatography (HPLC). Endogenous formaldehyde dramatically increased in cultured MRMT-1 breast cancer cells in vitro, in bone marrows and sera of bone cancer pain rats, in tumor tissues and sera of MRMT-1 subcutaneous vaccination model rats in vivo. Formaldehyde at a concentration as low as the above measured (3 mM) induced pain behaviors in normal rats. The expression of LSD1 which mainly located in nuclei of cancer cells significantly increased in bone marrows of bone cancer pain rats from 14 d to 21 d after inoculation. Furthermore, inhibition of LSD1 decreased the production of formaldehyde in MRMT-1 cells in vitro. Intraperitoneal injection of LSD1 inhibitor pargyline from 3 d to 14 d after inoculation of MRMT-1 cancer cells reduced bone cancer pain behaviors.
Our data in the present study, combing our previous report, suggested that in the endogenous formaldehyde-induced pain in bone cancer pain rats, LSD1 in metastasized cancer cells contributed to the production of the endogenous formaldehyde.
骨癌疼痛严重影响癌症患者的生活质量。我们之前的研究发现,转移性癌细胞在骨髓中产生内源性甲醛,并在骨癌痛中发挥重要作用。然而,转移性癌细胞在骨癌痛大鼠中产生这种内源性甲醛的机制尚不清楚。赖氨酸特异性去甲基酶 1(LSD1)是催化甲醛产生的主要酶之一。LSD1 的表达和甲醛浓度在许多高危肿瘤中上调。
本研究旨在探讨骨髓中转移性 MRMT-1 乳腺癌细胞中的 LSD1 是否参与骨癌痛大鼠内源性甲醛的产生。
方法/主要发现:采用高效液相色谱法(HPLC)测定内源性甲醛浓度。体外培养的 MRMT-1 乳腺癌细胞、骨癌痛大鼠骨髓和血清、体内 MRMT-1 皮下接种模型大鼠肿瘤组织和血清中内源性甲醛浓度均显著升高。上述测量浓度(3mM)的甲醛即可诱导正常大鼠产生痛行为。骨癌痛大鼠骨髓中 LSD1 的表达(主要位于癌细胞核内)从接种后第 14 天到第 21 天显著增加。此外,抑制 LSD1 可减少 MRMT-1 细胞体外甲醛的产生。MRMT-1 癌细胞接种后第 3 天至第 14 天腹腔注射 LSD1 抑制剂帕吉林可减轻骨癌痛行为。
本研究结合我们之前的报告数据表明,在骨癌痛大鼠内源性甲醛诱导的疼痛中,转移性癌细胞中的 LSD1 有助于内源性甲醛的产生。